Page Updated: Monday, March 18, 2024 9:58 PM ET

CNBC - Opinion

Top Wall Street analysts prefer these three stocks for the long haul

1 day ago

Insana: A market shake-up could be around the corner as inflation remains sticky

1 day ago

Top Wall Street analysts recommend these 3 dividend stocks

8 days ago

Activist Petrus has a plan to help lift Criteo's share price. How it may unfold

8 days ago

Top Wall Street analysts recommend these 3 stocks for the long term

15 days ago

Elliott calls for changes at Mitsui Fudosan: 3 possible steps to create value

15 days ago

Top Wall Street analysts pick these dividend stocks for enhanced returns

22 days ago

Starboard nominates directors to Alight's board. How the firm could help boost margins

22 days ago

Top Wall Street analysts like these 3 stocks for long-term growth

1 month ago

Carl Icahn gets two seats on JetBlue's board. Here's how he may help build value

1 month ago

Top Wall Street analysts pick these 3 dividend stocks for the long haul

1 month ago

Activist Ancora may turn to a reliable tactic to enhance value at Norfolk Southern

1 month ago

Insana: Fed may move slowly to cut rates, but this is still a good economy

1 month ago

Top Wall Street analysts suggest these 3 stocks for solid upside

1 month ago

Top Wall Street analysts are upbeat about these 3 dividend stocks

1 month ago

How activist Rubric Capital may help enhance shareholder value at Xperi

1 month ago

Top Wall Street analysts pick these stocks for solid returns

1 month ago

Ron Insana: Even with January's rocky start, 2024 could still be a solid year for stocks

1 month ago

Four predictions for 2024: Brian Sullivan's outlook for the new year

19 days ago

Top Wall Street analysts recommend these stocks for dividend-oriented investors

2 months ago

Activist Elliott spots an opportunity to restore growth at Match. Here's what may happen next

2 months ago

Top Wall Street analysts prefer these 3 stocks for long-term growth

2 months ago

How ValueAct may help boost margins at this Japanese medical device company

2 months ago

Ron Insana: Here's why 2024 just might be a 'normal' year for the U.S. economy

2 months ago

Top Wall Street analysts suggest these 3 dividend picks for 2024

2 months ago

Ancora picks up a stake in Elanco. How the investor may push to improve margins

2 months ago

Investor Michael Farr is back with this top 10 stocks he's buying for 2024

2 months ago

Top Wall Street analysts like these stocks for their growth potential

2 months ago

Cevian's track record with banks could help the activist build value at UBS

2 months ago

Insana: November's inflation reading is a holiday gift for the Fed

2 months ago

Asia's year in review: Who had it good — and who had it bad — in 2023

2 months ago

Top Wall Street analysts favor these 3 dividend stocks for the long haul

3 months ago

Investor Karen Firestone has her radar on this corner of the market in 2024

3 months ago

Top Wall Street analysts are confident about these 3 promising stocks

3 months ago

How activist Palliser may build value at Korean industrial giant Samsung C&T

3 months ago